HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECHA, Trade Unions Collaborate To Push REACH Compliance

This article was originally published in The Rose Sheet

Executive Summary

Fearing that many small and medium-sized personal-care companies will face fines or production stoppages for not being REACH-compliant, the European Chemicals Agency and two union trade associations are working to raise awareness of the 2013 deadline and firms’ responsibilities under Europe’s chemicals registration program.

You may also be interested in...



EU Chemicals Agency Leverages 2010 Lessons To Ready Firms For REACH 2013

With the passing of the first registration deadline under Europe’s REACH program and the evaluation of registered dossiers underway, the European Chemicals Agency is working to motivate and support companies subject to the next deadline.

"Many" REACH Dossiers Had Quality Problems In 2010, Says ECHA

"Many" of the REACH dossiers evaluated by the European Chemicals Agency in 2010 had "at least some quality problems," but they should not be considered representative of all submissions received by the Nov. 30, 2010 deadline, ECHA says.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018176

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel